New diabetes clinical trial: Clinical Trial to Evaluate the Pharmacokinetics and Safety Between the Single Administration of HL1113 and the Concomitant Administration of HL1113R1 and HL1113R2 for Healthy Subjects in Fasting State

Published on: 2026-05-06T04:00:00Z
Conditions: Hypertension; Diabete Type 2
Interventions: Drug: Test group 1; Drug: Test group 2
Sponsors: Hanlim Pharm. Co., Ltd.
Completed
https://ift.tt/SXcF9nj